Passive and Carrier-Mediated Intestinal Absorption Components of Two Angiotensin Converting Enzyme (ACE) Inhibitor Prodrugs in Rats: Enalapril and Fosinopril

Pharmaceutical Research - Tập 6 Số 12 - Trang 1043-1047 - 1989
Friedman, Doron I.1, Amidon, Gordon L.
1College of Pharmacy, The University of Michigan, Ann Arbor

Tóm tắt

The intestinal absorption mechanism of two ACE inhibitor prodrugs, enalapril and fosinopril, was investigated in rats using a single-pass perfusion method. A modified boundary layer solution was applied to determine the apparent intestinal wall permeability. The prodrug enalapril is well absorbed from rat jejunum, whereas the parent drug, enalaprilat, is poorly absorbed. The permeability of enalapril is concentration dependent and is decreased by the dipeptide Tyr-Gly and by cephradine but not by the amino acids L-leucine or L-phenylalanine, indicating a nonpassive absorption mechanism via the small peptide carrier-mediated transport system. In contrast, fosinopril is readily absorbed by a concentration-independent mechanism without the involvement of the peptide carrier.

Từ khóa


Tài liệu tham khảo

citation_journal_title=J. Pharm. Sci.; citation_author=M. Hu, G. L. Amidon; citation_volume=77; citation_publication_date=1988; citation_pages=1007-1011; citation_id=CR1

citation_journal_title=Br. J. Clin. Pharmac.; citation_author=A. F. Lant; citation_volume=23; citation_publication_date=1987; citation_pages=27S-41S; citation_id=CR2

citation_journal_title=Clin. Pharmacol. Ther.; citation_author=J. Bussien, T. F. D'Amore, L. Perret, M. Prchet, J. Nussberger, B. Waeber, H. R. Brunner; citation_volume=39; citation_publication_date=1986; citation_pages=554-558; citation_id=CR3

citation_journal_title=Drugs; citation_author=F. Fyhrquist; citation_volume=32; citation_publication_date=1986; citation_pages=33-39; citation_id=CR4

citation_journal_title=Clin. Sci.; citation_author=N. Nakashima, K. Nishijima; citation_volume=63; citation_publication_date=1982; citation_pages=183-185; citation_id=CR5

citation_journal_title=Clin. Pharm.; citation_author=P. H. Vlasses, G. E. Larijani, D. P. Conner, R. K. Ferguson; citation_volume=4; citation_publication_date=1985; citation_pages=27-40; citation_id=CR6

citation_inbook_title=Angiotensin Converting Enzyme Inhibitors; citation_publication_date=1987; citation_pages=213-261; citation_id=CR7; citation_author=E. A. DeFelice; citation_author=J. B. Kostis; citation_publisher=Alan R. Liss

citation_inbook_title=Directed Drug Delivery; citation_publication_date=1985; citation_pages=61-82; citation_id=CR8; citation_author=C. R. Gardner; citation_publisher=Humana Press

citation_journal_title=J. Pharmacol. Exp. Ther.; citation_author=K. S. Pang, W. F. Cherry, E. H. Ulm; citation_volume=233; citation_publication_date=1985; citation_pages=788-795; citation_id=CR9

citation_journal_title=J. Theor. Biol.; citation_author=D. A. Johnson, G. L. Amidon; citation_volume=131; citation_publication_date=1988; citation_pages=93-106; citation_id=CR10

citation_journal_title=Pharm. Res.; citation_author=P. J. Sinko, G. L. Amidon; citation_volume=5; citation_publication_date=1988; citation_pages=645-650; citation_id=CR11

P. J. Sinko and G. L. Amidon. Submitted for publication.

citation_journal_title=Drug Metabol. Disp.; citation_author=D. J. Tocco, F. A. Deluna, A. E. Duncan, T. C. Vassil, E. H. Ulm; citation_volume=10; citation_publication_date=1982; citation_pages=15-19; citation_id=CR13

citation_journal_title=Pharm. Res.; citation_author=G. L. Amidon, P. J. Sinko, D. Fleisher; citation_volume=5; citation_publication_date=1988; citation_pages=651-654; citation_id=CR14